Thiamin.

Thiamine only becomes active as thiamine pyrophosphate, and the kinase that makes it needs magnesium. The dehydrogenase complexes that then use the cofactor are magnesium dependent too, so thiamine cannot do its job when magnesium is short.

The alpha-ketoacid dehydrogenase complexes carry thiamine pyrophosphate at the first step and riboflavin-derived FAD at the reoxidation step. Both cofactors have to be present for the complex to turn over.

NAD derived from niacin is the final electron acceptor of the pyruvate dehydrogenase complex whose first step needs thiamine pyrophosphate. The two vitamins sit at opposite ends of the same reaction.

Thiamine pyrophosphate strips carbon dioxide from pyruvate and the remaining acetyl group is handed to coenzyme A, which is built from pantothenate. Low coenzyme A stalls the step that thiamine has just enabled.

Lipoamide accepts the acetyl group directly from thiamine pyrophosphate inside the pyruvate and alpha-ketoglutarate dehydrogenase complexes. The two cofactors sit side by side on the same multienzyme assembly.

Benfotiamine is an S-acyl thiamine derivative that crosses membranes without the saturable transporter that limits plain thiamine. It is dephosphorylated and converted to the same active thiamine pyrophosphate.

Allithiamine carries an open thiazole ring and a lipophilic side chain, so it passes membranes by diffusion and is reduced back to thiamine inside the cell. It bypasses the transporter ceiling that caps plain thiamine uptake.

Sulbutiamine is two thiamine molecules joined by a disulfide bridge with esterified side chains, which makes it far more lipophilic than thiamine. It is cleaved back to thiamine after crossing membranes.

B1, B6 and B12 are combined in the classic neurotropic formula because each supports a different part of normal nerve metabolism. B6 handles amino acid transamination while B1 handles the carbohydrate-derived carbon feeding the same cycle.

B12 is needed for methylmalonyl-CoA handling and methylation, while thiamine covers the decarboxylation steps of energy metabolism in the same tissue. Combining them is standard practice in B complex design.

Tannins oxidise the thiazole ring of thiamine to a form the body cannot use, a well documented antithiamine effect. Taking thiamine with a tannin-rich preparation lowers how much intact vitamin survives to be absorbed.

Black tea polyphenols carry the same antithiamine activity as isolated tannins and degrade thiamine in the gut lumen. Separating the two by an hour or two avoids the loss.

Thiamine is stable in acid and breaks down quickly as pH rises, with the thiazole ring opening under alkaline conditions. Co-formulating it with a strong alkalising agent shortens its shelf life.

A prospective, randomised, double-blind, placebo-controlled multicentre study used thiamin together with folic acid as a single intervention arm. Both are water-soluble B vitamins with separate cofactor roles, so the pairing is a co-administration design rather than a demonstrated chemical interaction. The trial result belongs to the combination, not to thiamin alone.

The thiazolium ring of thiamin opens in the presence of allicin-derived allyl disulfides and recloses as an open-chain disulfide, allithiamine. That derivative crosses membranes without needing the saturable thiamin transporters. This is the chemistry behind allithiamine as an ingredient and it is settled, not speculative.

Leucine is transaminated to its ketoacid and then decarboxylated by the branched-chain ketoacid dehydrogenase complex, which uses thiamin pyrophosphate at its E1 subunit. Without adequate thiamin that step stalls and the ketoacids accumulate. Higher branched-chain amino acid intake therefore draws on thiamin-dependent capacity.

All three branched-chain amino acids are decarboxylated by one complex whose E1 subunit is thiamin pyrophosphate dependent. Valine loading adds to the flux through that step. The relationship is textbook cofactor biochemistry.

Transketolase transfers two-carbon units between sugar phosphates and requires thiamin pyrophosphate to do it, which is why erythrocyte transketolase activity is used as a thiamin status marker. The non-oxidative branch it drives generates and consumes ribose-5-phosphate. Thiamin status is therefore upstream of endogenous ribose handling; the transketolase reading is a marker, not an outcome.

Carnitine carries long-chain fatty acids across the inner mitochondrial membrane; thiamin pyrophosphate lets pyruvate enter the TCA cycle through pyruvate dehydrogenase. The two govern the fat and carbohydrate entry routes to the same cycle. Pathway adjacency is not a measured combined effect.

Pyruvate dehydrogenase produces acetyl-CoA using thiamin pyrophosphate, and acetylcarnitine is the buffered store of that acetyl pool. The two ingredients therefore act on opposite sides of the same node. This describes the biochemistry, not a trial result.

Pyruvate and alpha-ketoglutarate dehydrogenase generate NADH, and CoQ10 carries electrons within the respiratory chain that consumes it. The two sit in sequence along the same energy pathway. Sequence is not synergy in the measured sense, and no combination trial defines this pair.

Pyruvate, alpha-ketoglutarate and branched-chain ketoacid dehydrogenases all reduce NAD+ at their E3 subunits, so NAD availability and thiamin pyrophosphate availability constrain the same reactions. NR raises NAD+ precursor supply. The two are complementary inputs to one complex rather than a tested pair.

Pyruvate can be decarboxylated by the thiamin-dependent dehydrogenase or carboxylated by pyruvate carboxylase, a manganese-activated, biotin-dependent enzyme. Which route dominates depends on the cell's energy state. The relationship is one of branch-point competition rather than mutual enhancement.

Thiamin degrades by oxidation to thiochrome and related products, faster at neutral to alkaline pH and in the presence of oxidants. A reducing agent such as ascorbate in the same liquid limits that loss. This is stability chemistry in the product, not an effect in the body.

Activated charcoal binds a wide range of small organic molecules in the gut lumen and does not distinguish a vitamin from anything else. Taken at the same time it can reduce the amount of thiamin available for absorption. Separating the doses by several hours is the conventional handling.

Thiamin carries a permanent positive charge on its thiazolium ring, which makes it a candidate for binding to a cation-exchanging clay. Taken together, less is left free for transport across the intestinal wall. The direction is mechanistic and the size of the effect is not quantified.

Thiamin salts are stable in acidic solution and break down progressively as pH climbs toward neutral and above. An acidifying co-ingredient keeps the local environment in the range where the molecule holds together. This is a stability and formulation point, not a claim about digestion.

Choline supplies the amine half of acetylcholine and the acetyl half comes from acetyl-CoA, whose main source is the thiamin-dependent pyruvate dehydrogenase reaction. Both inputs are therefore upstream of the same molecule. This is pathway biochemistry, and it does not by itself predict a cognitive effect.